bipolar disorder (BD) and depressive disorders. 3, [7] [8] [9] Reports have described associations between circadian rhythm abnormalities and mood disorders, given that circadian rhythm desynchronization plays a substantial role in the emergence of sleep disturbances that are closely associated with mood symptoms. [10] [11] [12] Sleep-wake cycle irregularities are commonly observed in patients with mood disorders. 13 Additionally, shifts in molecular circadian rhythm phases have been reported in patients with BD in whom phase delays and advances have been associated with different mood episodes, including depressive, manic, and mixed. 2, 3 Accordingly, some chronotherapeutic interventions developed to adjust circadian misalignments, such as bright light therapy (BLT), management of a regular sleep-wake cycle, and interpersonal and social rhythm therapy (IPSRT), have been used successfully to reduce the severity of BD. 3, [14] [15] [16] Moreover, the therapeutic mechanisms of lithium and valproate, which are frequently prescribed for the treatment of BD, have been attributed to the influences of these drugs on circadian genes and molecular clocks via the inhibition of glycogen synthase kinase-3β. 17, 18 Therefore, a biological rhythm assessment is not only important for identifying the cause of clinical symptoms, but also for the psychiatric treatment and clinical research of mood disorders. Currently, scales such as Seasonal Pattern Assessment Questionnaire (SPAQ) 19 and Morningness-Eveningness Questionnaire (MEQ) 20 are available for evaluating biological rhythm. However, these scales specifically evaluate chronotype or seasonality and are not sufficient for the direct evaluation of a subject's biological rhythm. Given the increasing emphasis on the importance of biological rhythm in the psychiatric field, the BRIAN was developed with a focus on biological rhythm and is considered highly valuable in research and clinical studies.
The objectives of this study were to examine the reliability and validity of the Korean version of the BRIAN (K-BRIAN) by examining the relevance of the scale for identifying circadian rhythm abnormalities. This study acknowledges the clinical relationship of circadian rhythm disturbances with the clinical manifestations of BD. The study was performed under the assumption that the preferred circadian phase may predict sleep and circadian rhythm alterations in patients with BD, given that previous studies have reported a greater circadian preference towards eveningness in many patients with BD types I and II. [8] [9] [10] 13, [21] [22] [23] Accordingly, we adopted another measure, the MEQ, 20 to test the concurrent validity of the K-BRIAN.
MEthods

Participants
One hundred and forty-one patients with a clinical diagnosis of BD under a subsyndromic clinical condition according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) 24 were recruited at 9 different hospitals participating in the Mood Disorder Cohort Research Consortium (MDCRC) study, 25 including Korea University Anam Hospital, Seoul National University Hospital, Seoul National University Bundang Hospital, Samsung Medical Center, Severance Hospital, Pusan National University Hospital, Gyeongsang National University Hospital, Cheonnam National University Hospital, and the National Center for Mental Health. Cases were diagnosed using the Mini-International Neuropsychiatric Interview (M.I.N.I.). 26 Sixty-nine subjects were diagnosed with BD I; the remaining subjects were diagnosed with BD II.
Forty control subjects were drawn randomly from the general population at Korea University Anam Hospital. The control group was balanced in terms of age and sex. In this group, 1 male subject was later excluded from the reliability analysis because he failed to answer all questions from the K-BRIAN during the retest assessment.
Informed consent was obtained from all subjects prior to the study. 
Assessments
The BRIAN comprises 18 items divided into 4 main areas related to circadian rhythm disturbances: sleep, social rhythms, activity, and eating pattern. Three additional items addressed predominant rhythm (i.e., chronotype). Particularly, the BRI-AN assesses the frequency of problems related to the maintenance of a regular circadian rhythm. The total BRIAN scores from the 18 items range from 18 to 72, with higher scores indicating a more severe circadian rhythm disturbance. The BRI-AN has been used in previous studies conducted in Brazil, 1 Spain, 27, 28 and Canada. 29 The BRIAN was translated from English to Korean by a lead researcher of the MDCRC. Forward-backward translations were used to maintain linguistic and conceptual equivalence. The K-BRIAN can be found in Supplementary Material (in the online-only Data Supplement). Prior to our work with the K-BRIAN, we received approval from the original author, Dr. Kapczinski, 1 and continued to discuss our progress with this author throughout the study.
The K-BRIAN was applied to the 141 patients with BD and 40 control subjects recruited for our study. Patients with BD were simultaneously evaluated using the MEQ scale 20 and K-BRIAN. These scales were to compare the abilities of these tests to determine chronotypes. The MEQ scale was designed to evaluate chronotype preferences in individuals. It includes 19 items for which all scores are summed in the evaluation. Subjects with higher scores are more likely to be categorized as the morning type, whereas those with lower scores tend to be categorized as the evening type. As previously mentioned, this study presumed that the eveningness chronotype may be used as preliminary evidence in an evaluation of circadian rhythm alterations, as this characteristic is prominent among individuals with BD or other mood disorders. [8] [9] [10] 13, 21, 30 Additionally, the reliability of K-BRIAN was determined in a testretest evaluation involving 40 control subjects. These subjects were evaluated twice at 4-week intervals, and the time points were identified as pre-and post-K-BRIAN. One male control subject failed to complete the post-K-BRIAN. statistical analyses SPSS 18 .0 for Windows (SPSS Inc., Chicago, IL, USA) was used to perform the statistical analysis. First, a 1-way analysis of variance (ANOVA) was used to test the construct validity of the K-BRIAN. The mean K-BRIAN scores of the patients with BD and control subjects were compared to examine whether the scale could determine abnormalities in biological rhythms among the former group. Second, the associations between the K-BRIAN and MEQ were analyzed by comparing the mean K-BRIAN and MEQ scores of the patients with BD. The concurrent validity of these scales was evaluated using a Pearson's correlation analysis. Third, Cronbach's alpha was used to evaluate the internal consistency of the K-BRIAN. The test-retest reliability of the pre-and post-K-BRIAN scores of the control group were compared using the paired samples t-test.
rEsults subject characteristics
The subjects' demographics were analyzed using descriptive statistics (Table 1 ). The mean (±standard deviation) ages of patients with BD types I and II were 23.32±2.66 and 22.87±2.70 years, respectively. There were slightly more female than male subjects among all patients with BD types I and II. The mean K-BRIAN score was higher among patients with BD type II (50.18±13.73) than among patients with BD type I (41.19±12.10). However, patients with BD type II received lower MEQ scores, compared to those with BD type I. As predicted, the eveningness chronotype was predominant in both groups.
The control group had a mean age of 24.76±4.46 years, similar to that of BD patients. In this group, the male/female ratio was exactly 50/50 because the control subjects were balanced in terms of sex. The mean K-BRIAN and MEQ scores among controls were 36.43±9.54 and 35.00±8.88, respectively. As in the BD groups, the eveningness chronotype was predominant in the control group.
comparison of K-BrIAn scores between patients with Bd and control subjects
As shown in Table 2 , the ANOVA revealed significant differences in BRIAN scores (F=22.43, p<0.001) among the 3 different groups (BD types I and II and controls). Post hoc comparisons (Tukey HSD test) also indicated a significantly lower mean K-BRIAN score for control subjects than for patients with BD type I (p<0.036) and BD type II (p<0.001). Furthermore, the mean K-BRIAN score among patients with BD type II was significantly higher than those among patients with BD type I (p<0.001) and control subjects (p<0.001). This pattern remained when the 5 different domains of the BRIAN were analyzed separately ( Table 3 ). The mean scores for each domain of the BRIAN revealed an increasing pattern dependent on the severity of the biological rhythm disruption. Specifically, higher BRIAN scores indicated greater overall biological rhythm disturbances, especially among patients with BD. 
Analysis of the correlation between K-BrAIn and MEQ
The analysis revealed a negative correlation between the 2 scales. A linear correlation was observed between these variables such that the MEQ score decreased as the BRIAN score increased. This pattern was expected because a low MEQ score indicates an eveningness chronotype, while a high BRI-AN score reveals biological rhythm disturbances. The correlation had an approximately moderate magnitude or strength and was statistically significant (r=-0.45, p<0.001).
reliability statistics of K-BrIAn
The K-BRIAN was found to be highly reliable for the evaluation of patients with BD. The Cronbach's alpha value of 0.914 indicated a high level of internal consistency for this scale (Table 4) . A test-retest reliability analysis of 39 control subjects revealed a moderate correlation (r=0.46, p<0.001) between the pre-(34.62±8.66) and post-K-BRIAN scores (33.59±6.92). A paired samples t-test revealed no significant intragroup difference between these pre-and post-K-BRAIN scores (t=0.775, p=0.443).
dIscussIon
We studied the validity and reliability of the K-BRIAN, which has been used to measure biological rhythm in psychiatric settings. Particularly, subjects with BD, which is known to associate closely with circadian rhythm disturbances, were compared with control subjects, and a significant intergroup difference was confirmed. The reliability of the K-BRIAN, confirmed through this study, was similar to that determined in previous studies of BRIAN.
1,4 The Cronbach's alpha values for the entire scale and for each item were very good and additionally confirmed the excellent reliability of K-BRIAN.
Biological rhythm can be measured at several stages. The traditional method involves continuous measurement of the core body temperature; 31 however, most approaches evaluate molecular and behavioral circadian rhythms, wherein the former can be confirmed by measuring changes in gene expression or hormone secretion and the latter can be measured using actigraphy or wearable devices. 12, [32] [33] [34] [35] Molecular-level measurements may be most accurate; however, this method remains cumbersome and invasive and is difficult to apply to a large number of subjects. Furthermore, although actigraphy or wearable devices can provide valuable behavior patternbased information related to biological rhythms, it is difficult to obtain this information directly without wearing a device. A biological rhythm measurement based on the K-BRIAN scale is subject to recall bias and dependent on the reliability of answers, 36, 37 but can be easily evaluated at any time; furthermore, the ability to assess 5 subdomains makes this scale an attractive clinical and research tool. Particularly, given the changes in seasonal characteristics throughout the year and the increased disturbance of circadian rhythms due to increased nighttime light exposure, a consequence of a significantly modernized and developed lifestyle, 38,39 the K-BRIAN can be useful for measuring disturbances in biological rhythm in a psychiatric context in Korea. In the present study, the K-BRIAN score was significantly higher in patients with BD than in normal controls. This is consistent with previous studies suggesting that patients with BD exhibit more disturbed biological rhythms as determined by the BRIAN. 8 Particularly, the higher K-BRIAN score of patients with BD type II relative to those with type I suggests a stronger association of the former type with biological rhythm disturbances. 30 This result can be interpreted in the context of previous studies, which reported a close relationship between biological rhythm disturbances and more frequent and severe depressive features in patients with BD II. 27, 28 Further investigation into the relationship between the frequency and severity of mood symptoms and the K-BRIAN will be needed in future. This finding provides important evidence regarding an approach based on biological rhythms in mood disorders research and clinical practices.
The correlation between the MEQ and K-BRIAN was significant and negative and suggested a reasonable degree of concurrent validity. In other words, the lower the MEQ score, the higher the K-BRIAN score. This finding suggests a possible relationship between a biological rhythm disturbance and the eveningness chronotype. Studies have shown that the eveningness chronotype is closely related to BD or seasonal affective disorder (SAD). [40] [41] [42] From this study, the eveningness chronotype appears more likely to disturb the biological rhythm, and both characteristics are closely related to BD. Patients with the eveningness chronotype often remain awake at night and are very likely to be exposed to inappropriate and unnecessary light while awake. A previous study reported that the molecular circadian rhythms of patients at a high-risk of mood disorder are much more easily disturbed by nighttime light exposure than those of patients at a low-risk. 12 The absence of the morningness chronotype and relatively high frequency of the eveningness chronotype on the MEQ in this study indicates changes in the lifestyles of modern Korean residents. This suggests that circadian rhythm vulnerability and rhythm disturbance factors such as nighttime light exposure, which is common among individuals with the eveningness chronotype, may induce and aggravate BD.
This study had some limitations. First, the study sample was relatively small. However, the combined group of patients with BD types I and II included a considerable number of subjects, which was superior to the sample sizes of previous BRIAN-related studies. 1, 4 Second, it was difficult to select a scale for comparison with K-BRIAN. Previous studies of BRI-AN used the same sleep scale as Pittsburgh Sleep Quality Assessment (PSQI); 1 however, we selected the MEQ to address biological rhythm. 20 Although a tool with a stronger focus on biological rhythm would be a better option, the MEQ is currently the best-available comparison tool.
In this study, we validated the Korean version of the BRI-AN, a scale actively used for biological rhythm measurements in a psychiatric context, and confirmed its validity and reliability in a Korean population. Notably, we observed a significantly higher K-BRIAN score in patients with BD than in normal subjects and confirmed a significant correlation of this scale with the MEQ. Despite some limitations of the K-BRIAN for evaluating biological rhythms, it appears to be a very useful tool for evaluation because it focuses on biological rhythms, unlike other scales that only indirectly measure biological rhythm by evaluating seasonality or chronotype. In the future, the K-BRIAN will likely be used for biological rhythm measurements in various psychiatric areas and for active research and clinical practice pertaining to mood disorders.
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